ACCU-CHEK POCKET COMPASS DIABETES MANAGEMENT SOFTWARE— 510(k) K050760

Name: FDA 510(k) clearance K050760
Creator: U.S. Food and Drug Administration
Published: 2005-09-13

Substantially Equivalent

Roche Diagnostics Corp.

FDA 510(k) clearance K050760 for ACCU-CHEK POCKET COMPASS DIABETES MANAGEMENT SOFTWARE, Substantially Equivalent on 2005-09-13. Applicant: Roche Diagnostics Corp.. Device class: 2.

Clearance details

Applicant: Roche Diagnostics Corp.
Product code: Code LZG
Device class: Class 2
Regulation: 21 CFR 880.5725
Advisory panel: General Hospital
Date received: 2005-03-24
Decision date: 2005-09-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LZG

view all

K253534 — Pivot Insulin Delivery System2026-04-08
K240158 — Modular Medical MODD1 Insulin Delivery System2024-09-04
K241622 — Extended Reservoir; MiniMed Reservoir2024-07-02
K223372 — Omnipod GO Insulin Delivery Device2023-04-24
K210714 — Extended Reservoir2022-04-06

More clearances from Roche Diagnostics Corp.

view all

K130138 — SUPER SANI-CLOTH/ ACCU-CHEK INFORM II SYSTEM2013-03-15
K101365 — ELECSYS CA 19-9 CALCHECK 52010-10-05
K100853 — COBAS 8000 MODULAR SERIES ANALYZER2010-09-09
K101196 — ACCU-CHEK ULTRFLEX INFUSION SET2010-08-27
K093664 — AMPHETAMINES II ASSAY2010-07-28

Adverse events under product code LZG

product code LZG

Death: 104
Injury: 12,022
Malfunction: 135,004
Other: 1
Total: 147,131

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.